Randomized, double-blind, parallel-controlled clinical trial on correspondence of prescriptions and Traditional Chinese Medicine syndrome of ischemic stroke

被引:9
|
作者
Gao, Ying [1 ]
Zhong, Haizhen [2 ]
Ma, Bin [1 ]
Huang, Yue [1 ]
机构
[1] Beijing Univ Chinese Med, Dongzhimen Hosp, Dept Neurol, Beijing 100700, Peoples R China
[2] Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China
关键词
Stroke; Classical prescriptions; Symptom complex; Multicenter study;
D O I
10.1016/S0254-6272(13)60034-5
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
OBJECTIVE: To investigate the effect of correspondence of prescriptions and the traditional Chinese medicine (TCM) syndrome of ischemic stroke. METHODS: Based on standard syndrome diagnosis and a series of effective formulas, a randomized, double-blind, parallel-controlled clinical trial on correspondence of prescriptions and the TCM syndrome of ischemic stroke was conducted. The formulas were dynamically changed according to the patient's TCM syndrome. RESULTS: The treatment was composed of a series of formulas changed daily according to the TCM syndrome. Treatments which were composed of a series of formulas had similar short-term (1 month after onset) effects in improving mild and moderate neurological deficits compared with treatments composed of only one formula. However, patients treated with a series of formulas showed improved subjective symptoms in the short-term and a decreased risk of stroke recurrence within three months after onset. CONCLUSION: Complete (series of formulas) and incomplete (only one formula) correspondence of prescriptions and TCM syndrome have similar effects on the central clinical manifestation of ischemic stroke, such as neurological deficit and activities in daily living. However, they have significant differences regarding individual dysfunctions, such as subjective symptoms. (C) 2012 JTCM. All rights reserved.
引用
收藏
页码:335 / 342
页数:8
相关论文
共 50 条
  • [21] A RANDOMIZED DOUBLE-BLIND CONTROLLED TRIAL OF NAFTIDROFURYL IN ACUTE STROKE
    GRAY, CS
    FRENCH, JM
    VENABLES, GS
    CARTLIDGE, NEF
    JAMES, OFW
    BATES, D
    AGE AND AGEING, 1990, 19 (06) : 356 - 363
  • [22] Traditional Chinese medicine syndrome differentiation and treatment by stages of Parkinson's disease: study protocol for a multicentre, randomized, double-blind, placebo-controlled clinical trial
    Hu, Yuqing
    Gu, Sichun
    Yuan, Xiaolei
    Li, Hui
    Yuan, Canxing
    Ye, Qing
    CHINESE MEDICINE, 2022, 17 (01)
  • [23] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF NIMODIPINE IN ACUTE ISCHEMIC HEMISPHERIC STROKE
    KASTE, M
    FOGELHOLM, R
    ERILA, T
    PALOMAKI, H
    MURROS, K
    RISSANEN, A
    SARNA, S
    STROKE, 1994, 25 (07) : 1348 - 1353
  • [24] Pharmacokinetics, Safety, and Immunogenicity of a Biosimilar of Nivolumab (LY01015): A Randomized, Double-Blind, Parallel-Controlled Phase I Clinical Trial in Healthy Chinese Male Subjects
    Wang, Wei
    Zhang, Shengnan
    Dou, Changlin
    Hu, Baihui
    Song, Hongtao
    Qi, Fan
    Zhao, Yanyan
    Li, Xiaojing
    Zhou, Ming
    Xie, Jinlian
    Deng, Kunhong
    Wu, Qian
    Ye, Ling
    Cui, Chang
    Liu, Li
    Huang, Jie
    Yang, Guoping
    BIODRUGS, 2024, 38 (06) : 855 - 865
  • [25] Effects of Kamishoyosan, a Traditional Japanese Medicine, on Menopausal Symptoms: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial
    Takamatsu, Kiyoshi
    Ogawa, Mariko
    Higuchi, Tsuyoshi
    Takeda, Takashi
    Hayashi, Kunihiko
    Mizunuma, Hideki
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2020, 2020
  • [26] Efficacy and safety of aripiprazole in Chinese Han schizophrenia subjects: A randomized, double-blind, active parallel-controlled, multicenter clinical trial (vol 157, pg 112, 2014)
    Li, Huafang
    Luo, Jianfeng
    ChuanyueWang
    Xie, Shiping
    Xu, Xiufeng
    XiaopingWang
    Yu, Wenjuan
    Gu, Niufan
    Kane, John M.
    SCHIZOPHRENIA RESEARCH, 2014, 159 (01) : 256 - 256
  • [27] Wangbi capsule for active rheumatoid arthritis:a multicenter,randomized,double-blind,parallel-controlled study
    吴金联
    China Medical Abstracts(Internal Medicine), 2024, 41 (02) : 80 - 81
  • [28] The efficacy of H008 tablets for duodenal ulcer: A phase II randomized, double-blind, parallel-controlled trial
    Tan, Niandi
    Liu, Xiaowei
    Liu, Chengxia
    Li, Shengbao
    Chen, Honghui
    Li, Xing
    Wu, Hao
    Liao, Aijun
    Zhen, Yanbo
    Shen, Pengzhen
    Huo, Lijuan
    Liu, Hongling
    Shi, Ruihua
    Zhang, Bingqiang
    Zhan, Zhenyu
    Wang, Jianning
    Zhan, Qiang
    Deng, Hong
    Shu, Xu
    Tuo, Biguang
    Wang, Qizhi
    Du, Shiyu
    Qi, Lingzhi
    Zhang, Guoxin
    Peng, Qiong
    Wang, Bangmao
    Ye, Bin
    Chen, Minhu
    Xiao, Yinglian
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 72 - 72
  • [29] The efficacy of H008 tablets for duodenal ulcer: A phase II randomized, double-blind, parallel-controlled trial
    Tan, Niandi
    Liu, Xiaowei
    Liu, Chengxia
    Li, Shengbao
    Chen, Honghui
    Li, Xing
    Wu, Hao
    Liao, Aijun
    Zhen, Yanbo
    Shen, Pengzhen
    Huo, Lijuan
    Liu, Hongling
    Shi, Ruihua
    Zhang, Bingqiang
    Zhan, Zhenyu
    Wang, Jianning
    Zhan, Qiang
    Deng, Hong
    Shu, Xu
    Tuo, Biguang
    Wang, Qizhi
    Du, Shiyu
    Qi, Lingzhi
    Zhang, Guoxin
    Peng, Qiong
    Wang, Bangmao
    Ye, Bin
    Chen, Minhu
    Xiao, Yinglian
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 72 - 72
  • [30] Evaluation of the traditional Chinese medicine Shensongyangxin capsule on treating premature ventricular contractions: a randomized, double-blind, controlled multicenter trial
    ZOU Jiangang
    ZHANG Jian
    JIA Zhenhua
    CAO Kejiang
    CHINESEMEDICALJOURNAL, 2011, (01)